CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer

CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer

Tumor microenvironment (TME) plays an essential role in the development and metastasis of breast cancer (BC). More studies are needed on the differences and functions of immune components and matrix components. In this study, we calculated the proportion of tumor-infiltrating immune cells (TICs) and...

Full description

Bibliographic Details
Main Authors: Jianxin Wang, Guangchen Zhang, Yang Sui, Zhuowen Yang, Yinzhu Chu, Hailing Tang, Binbin Guo, Cong Zhang, Changjun Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Genetics
Subjects:
breast cancer
CD52
tumor microenvironment
immune infiltration
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2020.578002/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2020.578002/full

Similar Items